Objective To study the impacts of 1) the delay from the onset of symptoms to the institution of
disease‐modifying antirheumatic drug (DMARD) therapy, 2) two treatment strategies (…

Background The treatment of rheumatoid arthritis should aim at clinical remission. This
multicentre, randomised trial with 2-year follow-up sought evidence on the efficacy and tolerability …

Background Reaching the therapeutic target of remission or low-disease activity has
improved outcomes in patients with rheumatoid arthritis (RA) significantly. The treat-to-target …

Objective To evaluate the impact of a 2‐year program of strength training on muscle strength,
bone mineral density (BMD), physical function, joint damage, and disease activity in …

Objective To evaluate the long‐term frequency of disease remissions and the progression of
joint damage in patients with early rheumatoid arthritis (RA) who were initially randomized …

Objective To explore the impact of an early treatment response on maintenance of work
capacity in patients with early, active rheumatoid arthritis (RA). Methods In the Finnish …

Objectives: To study which cut off point of DAS28 corresponds to fulfilment of the American
Rheumatism Association (ARA) preliminary remission criteria, and clinical remission criteria …

Objective The Health Assessment Questionnaire (HAQ) disability index (DI) has been
commonly used in rheumatology to quantify functional disability in patient groups, but current …

Objective To compare the efficacy of therapy with a combination of disease‐modifying
antirheumatic drugs (DMARDs) versus therapy with a single DMARD in the prevention of work …

Objective To compare Health Assessment Questionnaire (HAQ) scores of patients with
rheumatoid arthritis (RA) with HAQ scores from a sex‐ and age‐adjusted population. Methods …